Nirtetralin
Nirtetralin is a lignan. Nirtetralin can be isolated from Phyllanthus urinaria, Phyllanthus virgatus Forst. f., and Phyllanthus niruri L. Nirtetralin undergoes metabolic activation to generate active intermediates, such as nitroalkene ions and nitroso compounds, which can form DNA adducts and induce DNA damage. Nirtetralin induces ROS production in cells. Nirtetralin blocks the epithelial-mesenchymal transition process of cancer cells by altering the expression of related markers. Nirtetralin inhibits the production of HBsAg and HBeAg. Nirtetralin exhibits anticancer activity against oral squamous cell carcinoma. Nirtetralin can be used in studies of oral squamous cell carcinoma and hepatitis B virus infection.
For research use only. We do not sell to patients.
- CAS No.: 50656-78-5
- Formula: C24H30O7
- Molecular Weight:430.50
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All DNA/RNA Synthesis Isoforms
More
Biological Activity
Description
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| KB | IC50 |
159.15 μM
|
Antiproliferative activity against human KB oral squamous carcinoma cells assessed as reduction in cell viability incubated for 24 hrs by MTT assay.
Antiproliferative activity against human KB oral squamous carcinoma cells assessed as reduction in cell viability incubated for 24 hrs by MTT assay.
|
40353242 |
| KB | IC50 |
75.89 μM
|
Antiproliferative activity against human KB oral squamous carcinoma cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay.
Antiproliferative activity against human KB oral squamous carcinoma cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay.
|
40353242 |
| MS-G2 | EC50 |
36.9 μM
|
Suppression of HBsAg production in HBV-producing MS-G2 cells assessed via ELISA after 3 days of incubation.
Suppression of HBsAg production in HBV-producing MS-G2 cells assessed via ELISA after 3 days of incubation.
|
12748977 |
In Vitro
Nirtetralin (10-120 μM; 24-48 h) inhibits the viability of KB oral squamous carcinoma cells in a dose- and time-dependent manner, with an IC50 of 159.15 μM at 24 hours and 75.89 μM at 48 hours[1].
Nirtetralin modulates epithelial-mesenchymal transition (EMT) in KB oral squamous carcinoma cells by upregulating CLD1 and downregulating ECADH, VIM, SNAIL1, and SLUG gene expression[1].
Nirtetralin (5-50 μM) non-cytotoxically suppresses HBsAg and HBeAg production in MS-G2 cells, with an EC50 of 36.9 μM for HBsAg inhibition and maximum inhibitions of 69.6% for HBsAg and 33.9% for HBeAg at 50 μM[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:KB oral squamous carcinoma cells
-
Concentration:10-120 μM (24 h incubation); 10-120 μM (48 h incubation)
-
Incubation Time:24 h; 48 h
-
Result:Caused a significant, dose-dependent decrease in KB cell viability, with a more pronounced cytotoxic effect after 48 hours compared to 24 hours.
Exhibited a half-maximal inhibitory concentration (IC50) of 159.15 μM after 24 hours of incubation.
Exhibited a half-maximal inhibitory concentration (IC50) of 75.89 μM after 48 hours of incubation.
-
Cell Line:MS-G2 cells
-
Concentration:5-50 μM
-
Incubation Time:Unclear
-
Result:Suppressed HBsAg production by 69.6% at 50 μM.
Suppressed HBeAg production by 33.9% at 50 μM.
Suppressed HBsAg production by 32.1% at 25 μM.
Suppressed HBeAg production by 23.7% at 25 μM.
Suppressed HBsAg production by 22.4% at 5 μM.
Exhibited no significant effect on HBeAg production at 5 μM.
Achieved an EC50 of 36.9 μM for HBsAg suppression.
Chemical Information
-
CAS No. 50656-78-5
-
Molecular Weight 430.50
-
Formula C24H30O7
-
SMILES
O(C)C=1C=2[C@H]([C@H](COC)[C@@H](COC)CC2C=C3C1OCO3)C4=CC(OC)=C(OC)C=C4
-
Structure Classification
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
RNA extraction experimental
By lysing cells, releasing RNA, and removing impurities such as proteins and DNA, high-purity RNA products are finally obtained. The commonly used traditional method is the guanidine isothiocyanate/phenol/chloroform method (Trizol), which is suitable for a variety of animal materials including animal tissues, microorganisms, cultured cells, etc., and most plant materials.
-
Research Protocol for Infectious Diseases
Infectious-disease experiments test how pathogens interact with host barriers, innate immune receptors, inflammatory signaling, pathogen replication, and tissue injury; pattern-recognition receptors such as TLRs, RIG-I-like receptors, NOD-like receptors, and inflammasomes detect microbial molecules and activate NF-κB, interferon, and cytokine responses. The central hypothesis is that infection severity reflects the balance between pathogen burden and host response: protective inflammation restricts pathogen growth, whereas excessive or mislocalized inflammation contributes to tissue damage and disease phenotype. Unresolved questions include which host pathways are protective versus pathogenic, why some infection models fail to translate to human disease, and which combined readouts best predict clinically relevant infection outcomes.
-
ROS/oxidative-stress fluorescent staining
ROS/oxidative-stress fluorescent staining uses cell-permeant fluorogenic probes that become fluorescent after oxidation inside cells or tissues; commonly used examples include DCFH-DA/DCFDA for broad cellular oxidant detection, DHE for superoxide-related signal detection, MitoSOX for mitochondrial superoxide-related signal detection, and CellROX probes for oxidative-stress-associated fluorescence readouts. The assay detects probe oxidation rather than a single ROS species unless the probe and analysis method have been chemically validated for that species. DCFH-DA enters cells, is deacetylated by intracellular esterases to DCFH, and produces fluorescent DCF after oxidation, so the readout is used as an operational measure of total cellular oxidative stress rather than a species-specific ROS measurement. DHE and MitoSOX can report superoxide-related oxidation, but red fluorescence alone can include non-specific ethidium-like oxidation products; HPLC or optimized spectral approaches are
-
Genotoxicity/Mutagenicity Study
The bacterial reverse mutation assay detects point mutations that restore amino-acid prototrophy in auxotrophic Salmonella typhimurium or Escherichia coli tester strains; after exposure to a test article, mutagenic activity is read out as an increased number of revertant colonies on minimal agar compared with the vehicle control. The assay uses tester strains with different mutation targets so that base-substitution and frameshift mutagens can be detected, and testing is performed with and without exogenous mammalian metabolic activation because some chemicals require biotransformation to become mutagenic.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- Nirtetralin
- 50656-78-5
- DNA/RNA Synthesis
- Reactive Oxygen Species (ROS)
- HBV
- blood-brain barrier
- epithelial-mesenchymal transition
- reactive oxygen species
- Phyllanthus niruri L.
- Phyllanthus virgatus Forst. f.
- oral squamous cell carcinoma cells
- hepatitis B virus
- KB oral squamous carcinoma cells
- MS-G2 cells
- Phyllanthus urinaria
- Inhibitor
- inhibitor
- inhibit